DRD2 and amyotrophic lateral sclerosis: Additionally, D2R agonists such as Bromocriptine and Sumanirole(both represented in Figure 10, panels B and C, respectively) were tested by Huang et al., whoreportedthat the final effect of such activity on ALS models was an increase in motor neuron survival [53].